ELN.DE - Elanix Biotechnologies AG

XETRA - XETRA Delayed Price. Currency in EUR
Currency in EUR

Valuation Measures

Market Cap (intraday) 521.98M
Enterprise Value 318.1M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)261.38
Price/Book (mrq)1.12
Enterprise Value/Revenue 3215.23
Enterprise Value/EBITDA 6-18.95

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,566.29%

Management Effectiveness

Return on Assets (ttm)-5.86%
Return on Equity (ttm)-16.49%

Income Statement

Revenue (ttm)84.07k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-37.75k
EBITDA -955.12k
Net Income Avi to Common (ttm)-2.78M
Diluted EPS (ttm)-0.47
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.28M
Total Cash Per Share (mrq)0.36
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.62
Book Value Per Share (mrq)2.84

Cash Flow Statement

Operating Cash Flow (ttm)-2.09M
Levered Free Cash Flow (ttm)-122.87k

Trading Information

Stock Price History

Beta N/A
52-Week Change 3-36.00%
S&P500 52-Week Change 324.06%
52 Week High 38.30
52 Week Low 32.91
50-Day Moving Average 33.54
200-Day Moving Average 33.54

Share Statistics

Avg Vol (3 month) 312.3k
Avg Vol (10 day) 315.43k
Shares Outstanding 56.37M
Float 2.79M
% Held by Insiders 156.62%
% Held by Institutions 10.00%
Shares Short 3N/A
Short Ratio 3N/A
Short % of Float 3N/A
Shares Short (prior month) 3N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A